Shakeri, Ahmad, and Christopher Adanty. “Romosozumab (sclerostin Monoclonal Antibody) for the Treatment of Osteoporosis in Postmenopausal Women: A Review”. Journal of Population Therapeutics and Clinical Pharmacology 27, no. 1 (January 6, 2020): e25-e31. Accessed November 18, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/655.